| Name | Pantoprazole sodium hydrate |
|---|---|
| Synonyms |
6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt hydrate (2:2:3)
Pantoprazole (sodium hydrate) |
| Description | Pantoprazole sodium hydrate is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.IC50 value:Target: proton pump inhibitor |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H15F2N3O4S.3/2H2O.Na |
|---|---|
| Molecular Weight | 433.38 |
| Water Solubility | Freely soluble in water and in ethanol (96 per cent), practically insoluble in hexane. |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Phrases | 22 |
| RIDADR | NONH for all modes of transport |